This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Chromosome 1 (human) | |
|---|---|
| Name | Chromosome 1 |
| Caption | Human chromosome 1 ideogram |
| Type | Autosomal |
| Length | ~248 million base pairs |
| Genes | ~2,000–2,100 (protein-coding) |
| Banding | G-banding pattern |
Chromosome 1 (human) is the largest human chromosome by physical length and gene content, encompassing roughly 8% of the human genome sequence. It contains a high concentration of protein-coding loci and regulatory regions that influence traits and diseases studied by institutions such as the National Institutes of Health and projects like the Human Genome Project. Chromosome 1 has been central to genetic association studies involving consortia including the 1000 Genomes Project and the International HapMap Project.
Chromosome 1 spans approximately 248 million base pairs and is submetacentric, with distinct p (short) and q (long) arms visualized in karyotypes used in clinical cytogenetics departments at hospitals like Mayo Clinic and research centers such as the Broad Institute. Historical mapping efforts involved laboratories led by figures associated with the Cold Spring Harbor Laboratory and the Sanger Institute. Cytogenetic banding allowed early correlation between chromosomal loci and syndromes reported by clinicians at institutions like Johns Hopkins Hospital and universities including Harvard University.
The structural organization of Chromosome 1 includes euchromatic regions rich in genes and heterochromatic domains with repetitive elements studied by researchers at the Max Planck Institute and the Wellcome Trust. Its centromere position defines p and q arms used in nomenclature employed by the American College of Medical Genetics and Genomics. High-resolution maps integrate data from platforms developed by companies such as Illumina and facilities like the European Bioinformatics Institute. Large segmental duplications and copy number variants on Chromosome 1 have been characterized using methods refined at the Howard Hughes Medical Institute and in projects like the ENCODE Project.
Chromosome 1 contains an estimated 2,000–2,100 protein-coding genes cataloged by databases maintained by organizations such as the National Center for Biotechnology Information and the European Molecular Biology Laboratory. Well-known loci include genes implicated in metabolism and signaling studied in clinics at Cleveland Clinic and laboratories at Stanford University; examples of prominent genes mapped to Chromosome 1 are those investigated in landmark studies at Dana-Farber Cancer Institute and the Fred Hutchinson Cancer Center. Gene density varies along the chromosome, a pattern observed in comparative datasets generated by the Genome Research Limited and international collaborators like the Wellcome Sanger Institute teams.
The genes on Chromosome 1 encode proteins essential for cellular processes characterized in model systems used at institutions such as Massachusetts Institute of Technology and University of California, Berkeley. Pathways involving Chromosome 1 genes intersect with networks explored by consortia like the Human Proteome Organization and the International Cancer Genome Consortium. Regulatory elements on Chromosome 1 contribute to transcriptional programs relevant to developmental biology studies at the Karolinska Institute and neurobiology research at the Salk Institute. Functional annotations derive from experiments funded by agencies such as the National Science Foundation and coordinated with panels at the Royal Society.
Numerous Mendelian and complex disorders map to loci on Chromosome 1, with clinical genetics centers at Mayo Clinic and Cincinnati Children's Hospital Medical Center reporting cases involving deletions, duplications, and point mutations. Associations between Chromosome 1 variants and conditions like cancer have been advanced by clinical trials overseen by the National Cancer Institute and oncology groups such as the European Society for Medical Oncology. Single-gene disorders and syndromic presentations documented in case series from hospitals including Guy's and St Thomas' NHS Foundation Trust and research into cardiovascular risk loci led by teams at Imperial College London highlight the clinical impact of Chromosome 1. Diagnostic cytogenetics employs standards set by bodies such as the College of American Pathologists.
Comparative genomics of Chromosome 1 has involved model organisms and species sequenced by international efforts including the Genome 10K Project and the Zoonomia Project. Synteny maps reveal conserved blocks between human Chromosome 1 and chromosomes in species analyzed by researchers at the Smithsonian Institution and the Max Planck Institute for Evolutionary Anthropology. Studies on primate divergence reference specimens from institutions like the American Museum of Natural History and field teams collaborating with universities such as Oxford University. Patterns of evolution on Chromosome 1 inform theories discussed at meetings of societies like the Society for Molecular Biology and Evolution.
Sequencing and assembly of Chromosome 1 were major components of the Human Genome Project coordinated by centers including the Wellcome Trust Sanger Institute and the U.S. Department of Energy laboratories. Subsequent refinements used long-read technologies developed by companies like Pacific Biosciences and Oxford Nanopore Technologies and analytic methods from groups at the Broad Institute and the European Bioinformatics Institute. Large-scale association studies implicating Chromosome 1 loci have been published by international consortia such as the International HapMap Project and the 1000 Genomes Project, with interpretation aided by clinical cohorts assembled by entities like the Framingham Heart Study and biobanks such as the UK Biobank.
Category:Human chromosomes